TICKERNOMICS Sign up
Last Update: 2024-03-28 02:09:28
KONINKLIJKE PHILIPS NV ( PHG ) https://www.philips.com
20.04USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
Netherlands
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
PHG
28.94%
SPY
32.74%
-57.26%
PHG
SPY
92.93%
-33.28%
PHG
SPY
224.41%
PHG
6.57%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
19155.17
29202.96
0.65
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-29.36
1.00
1.45
-4.11
4.73
518.55
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
5.01
43.23
0.30
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
7.3659
3.75
4.09
0.83
Other Earnings and Cash Flow Stats:
KONINKLIJKE PHILIPS NV ( PHG ) Net Income TTM ($MM) is -2109.61
KONINKLIJKE PHILIPS NV ( PHG ) Operating Income TTM ($MM) is -1742.94
KONINKLIJKE PHILIPS NV ( PHG ) Owners' Earnings Annual ($MM) is 2950.43
KONINKLIJKE PHILIPS NV ( PHG ) Current Price to Owners' Earnings ratio is 6.96
KONINKLIJKE PHILIPS NV ( PHG ) EBITDA TTM ($MM) is -245.54
KONINKLIJKE PHILIPS NV ( PHG ) EBITDA Margin is 0.30%
Capital Allocation:
KONINKLIJKE PHILIPS NV ( PHG ) has paid 0.96 dividends per share and bought back -58.746138 million shares in the past 12 months
KONINKLIJKE PHILIPS NV ( PHG ) has reduced its debt by 837.7694 million USD in the last 12 months
Capital Structure:
KONINKLIJKE PHILIPS NV ( PHG ) Interest-bearing Debt ($MM) as of last quarter is 10056
KONINKLIJKE PHILIPS NV ( PHG ) Annual Working Capital Investments ($MM) are 9536
KONINKLIJKE PHILIPS NV ( PHG ) Book Value ($MM) as of last quarter is 13213
KONINKLIJKE PHILIPS NV ( PHG ) Debt/Capital as of last quarter is 76%
Other Balance Sheet Stats:
KONINKLIJKE PHILIPS NV ( PHG ) has 1043 million in cash on hand as of last quarter
KONINKLIJKE PHILIPS NV ( PHG ) has 8768 million of liabilities due within 12 months, and long term debt 8927 as of last quarter
KONINKLIJKE PHILIPS NV ( PHG ) has 940 common shares outstanding as of last quarter
KONINKLIJKE PHILIPS NV ( PHG ) has 0 million USD of preferred stock value
Academic Scores:
KONINKLIJKE PHILIPS NV ( PHG ) Altman Z-Score is 1.52 as of last quarter
KONINKLIJKE PHILIPS NV ( PHG ) Piotroski Score is 5.00 as of last quarter
Corporate Governance:
KONINKLIJKE PHILIPS NV ( PHG ) largest shareholder is owning shares at 0.00 ($MM) value
Philips Nv Koninklijke(an insider) Sold 3334586 shares of KONINKLIJKE PHILIPS NV ( PHG ) for the amount of $5001879.00 on 2017-10-11
0.00% of KONINKLIJKE PHILIPS NV ( PHG ) is held by insiders, and 7.32% is held by institutions
KONINKLIJKE PHILIPS NV ( PHG ) went public on 1987-12-30
Other KONINKLIJKE PHILIPS NV ( PHG ) financial metrics:
FCF:-3050.72
Unlevered Free Cash Flow:-11314.36
EPS:0.41
Operating Margin:5.01
Gross Profit Margin:43.23
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:2.19
Beta:0.83
Buffet's Owners Earnings:2950.43
Price to Owner's Earnings:6.96
About KONINKLIJKE PHILIPS NV ( PHG ) :
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. It has strategic partnership agreements with TriHealth, Prisma Health, and the University Health System of San Antonio to help the health system standardize patient monitoring, drive interoperability, and lay the foundation for enterprise-wide platform; and Oulu University Hospital to deliver advanced image-guided therapy solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.